Gender Impact On Physical Activity In Chronic Musculoskeletal Disorders Prevention
Condition(s) studied
Study summary
The goal of this survey based cross-sectional survey is to understand if there are gender patterns in physical activity participation and how they are associated with gendered organization of work and family activities, identifying socio-environmental variables that hamper the participation of both females and males in an active and healthy lifestyle. This survey also aim to explore if awareness and beliefs regarding musculoskeletal disorders and physical activity as factor for prevention differ according to gender and sex.
The main question is to investigate gender differences in physical activities participation in terms of adherence or not adherence to WHO recommendations by adjusting for socio-environmental variables.
The secondary questions are:
* To explore impact of gender on health status and sedentary behavior at same adherence and intensity level of physical activity
* To explore whether awareness and beliefs on musculoskeletal disorders and physical activity as prevention factor in the general population differ according to gender and sex.
Eligibility
Primary outcome measure(s)
- Adherence to WHO recommendations on physical activity — baseline (cross-sectional study)
Gender differences in the prevalence of adherents to WHO recommendations on physical activity assessed as a dichotomous variable (adherent or non-adherent), based on responses to the questions: "Can you quantify the amount of time you spend doing regular physical activity per week?" and "Can you quantify the usual intensity level (moderate/vigorous) of your physical activity per week?"
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Ospedale Galeazzi-Sant'Ambrogio | Milan | Italy | Recruiting |
More I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06747052 on ClinicalTrials.gov ↗ ← All trials in Italy